I will never understand the stance Peter Attia seems to take, which is that the participants in the LMHR study are at high risk and low risk simultaneously. After sticking to a strict keto diet, triglycerides decrease. HDL increases. The ratio between the two is favorable. BP decreases. HbA1c improves. BMI improves. Gut issues improve. Skin issues improve. People feel great, as Chris says. But, oh dear, LDL has increased, so Peter insists a drug intervention with a high incidence of unfavorable side effects is somehow the answer? That on its face is absurd! He and his friendly local Pfizer rep can live inside the Schrodinger's cholesterol box they have created, in which lean-mass hyper-responders are somehow both healthy and unhealthy at the same time.
The paper 'Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis' has just dropped in late August 2024 (Dr Nicholas is a coauthor) that has an interesting comparison between matched participants in the Miami Heart Study and those participating in Dave Feldman's Lean Mass Hyperresponders study.
Good discussion! I hope more research is done on LMHR! We need answers...
I will never understand the stance Peter Attia seems to take, which is that the participants in the LMHR study are at high risk and low risk simultaneously. After sticking to a strict keto diet, triglycerides decrease. HDL increases. The ratio between the two is favorable. BP decreases. HbA1c improves. BMI improves. Gut issues improve. Skin issues improve. People feel great, as Chris says. But, oh dear, LDL has increased, so Peter insists a drug intervention with a high incidence of unfavorable side effects is somehow the answer? That on its face is absurd! He and his friendly local Pfizer rep can live inside the Schrodinger's cholesterol box they have created, in which lean-mass hyper-responders are somehow both healthy and unhealthy at the same time.
The paper 'Carbohydrate Restriction-Induced Elevations in LDL-Cholesterol and Atherosclerosis' has just dropped in late August 2024 (Dr Nicholas is a coauthor) that has an interesting comparison between matched participants in the Miami Heart Study and those participating in Dave Feldman's Lean Mass Hyperresponders study.